nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCB1—peripheral nervous system neoplasm	0.178	1	CbGaD
Probenecid—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.105	0.147	CbGbCtD
Probenecid—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.0603	0.0842	CbGbCtD
Probenecid—ABCC6—Etoposide—peripheral nervous system neoplasm	0.0593	0.0828	CbGbCtD
Probenecid—ABCC5—Cisplatin—peripheral nervous system neoplasm	0.0461	0.0644	CbGbCtD
Probenecid—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.0404	0.0565	CbGbCtD
Probenecid—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0311	0.0434	CbGbCtD
Probenecid—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.031	0.0433	CbGbCtD
Probenecid—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0295	0.0411	CbGbCtD
Probenecid—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.029	0.0405	CbGbCtD
Probenecid—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0285	0.0398	CbGbCtD
Probenecid—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0224	0.0313	CbGbCtD
Probenecid—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0194	0.0271	CbGbCtD
Probenecid—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0191	0.0266	CbGbCtD
Probenecid—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0175	0.0244	CbGbCtD
Probenecid—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0161	0.0225	CbGbCtD
Probenecid—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0148	0.0207	CbGbCtD
Probenecid—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0141	0.0197	CbGbCtD
Probenecid—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0132	0.0184	CbGbCtD
Probenecid—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0129	0.0181	CbGbCtD
Probenecid—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.0167	CbGbCtD
Probenecid—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0108	0.0151	CbGbCtD
Probenecid—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0108	0.0151	CbGbCtD
Probenecid—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0144	CbGbCtD
Probenecid—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00883	0.0123	CbGbCtD
Probenecid—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00748	0.0104	CbGbCtD
Probenecid—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00646	0.00902	CbGbCtD
Probenecid—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00623	0.0087	CbGbCtD
Probenecid—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00601	0.00839	CbGbCtD
Probenecid—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00461	0.00643	CbGbCtD
Probenecid—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00443	0.00618	CbGbCtD
Probenecid—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00429	0.006	CbGbCtD
Probenecid—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00422	0.00589	CbGbCtD
Probenecid—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00288	0.00402	CbGbCtD
Probenecid—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00276	0.00385	CbGbCtD
Probenecid—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00254	1	CbGdCrCtD
Probenecid—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00253	0.00353	CbGbCtD
Probenecid—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00241	CbGbCtD
Probenecid—Procaine—BCHE—peripheral nervous system neoplasm	0.00139	0.544	CrCbGaD
Probenecid—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.00101	0.0152	CcSEcCtD
Probenecid—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000976	0.0147	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.000832	0.0125	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.000832	0.0125	CcSEcCtD
Probenecid—Pollakiuria—Tretinoin—peripheral nervous system neoplasm	0.000737	0.0111	CcSEcCtD
Probenecid—Pollakiuria—Isotretinoin—peripheral nervous system neoplasm	0.000737	0.0111	CcSEcCtD
Probenecid—Procainamide—BCHE—peripheral nervous system neoplasm	0.000719	0.282	CrCbGaD
Probenecid—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.000706	0.0106	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.000706	0.0106	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.00068	0.0102	CcSEcCtD
Probenecid—Haematuria—Tretinoin—peripheral nervous system neoplasm	0.000679	0.0102	CcSEcCtD
Probenecid—Haematuria—Isotretinoin—peripheral nervous system neoplasm	0.000679	0.0102	CcSEcCtD
Probenecid—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.000661	0.00993	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.00947	CcSEcCtD
Probenecid—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.000604	0.00908	CcSEcCtD
Probenecid—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.000604	0.00908	CcSEcCtD
Probenecid—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.000593	0.00891	CcSEcCtD
Probenecid—Flushing—Tretinoin—peripheral nervous system neoplasm	0.000593	0.00891	CcSEcCtD
Probenecid—Flushing—Melphalan—peripheral nervous system neoplasm	0.000585	0.0088	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.000577	0.00867	CcSEcCtD
Probenecid—Alopecia—Topotecan—peripheral nervous system neoplasm	0.000569	0.00855	CcSEcCtD
Probenecid—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.000565	0.00849	CcSEcCtD
Probenecid—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.000565	0.00849	CcSEcCtD
Probenecid—Pollakiuria—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.0084	CcSEcCtD
Probenecid—Alopecia—Melphalan—peripheral nervous system neoplasm	0.000557	0.00838	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.00804	CcSEcCtD
Probenecid—Anaemia—Topotecan—peripheral nervous system neoplasm	0.000518	0.00779	CcSEcCtD
Probenecid—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.000514	0.00773	CcSEcCtD
Probenecid—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.000514	0.00773	CcSEcCtD
Probenecid—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.000514	0.00773	CcSEcCtD
Probenecid—Anaemia—Melphalan—peripheral nervous system neoplasm	0.000507	0.00763	CcSEcCtD
Probenecid—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000502	0.00754	CcSEcCtD
Probenecid—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000494	0.00742	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.000492	0.0074	CcSEcCtD
Probenecid—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000491	0.00739	CcSEcCtD
Probenecid—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000485	0.00729	CcSEcCtD
Probenecid—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000461	0.00694	CcSEcCtD
Probenecid—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.000458	0.00688	CcSEcCtD
Probenecid—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000458	0.00688	CcSEcCtD
Probenecid—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000454	0.00682	CcSEcCtD
Probenecid—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000454	0.00682	CcSEcCtD
Probenecid—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00675	CcSEcCtD
Probenecid—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000448	0.00673	CcSEcCtD
Probenecid—Chlorpropamide—ABCB1—peripheral nervous system neoplasm	0.000443	0.174	CrCbGaD
Probenecid—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000436	0.00656	CcSEcCtD
Probenecid—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000433	0.0065	CcSEcCtD
Probenecid—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.0065	CcSEcCtD
Probenecid—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.00643	CcSEcCtD
Probenecid—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000427	0.00642	CcSEcCtD
Probenecid—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00042	0.00632	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000417	0.00627	CcSEcCtD
Probenecid—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000412	0.0062	CcSEcCtD
Probenecid—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000407	0.00612	CcSEcCtD
Probenecid—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000398	0.00598	CcSEcCtD
Probenecid—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000396	0.00595	CcSEcCtD
Probenecid—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000395	0.00593	CcSEcCtD
Probenecid—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000395	0.00593	CcSEcCtD
Probenecid—Pain—Topotecan—peripheral nervous system neoplasm	0.000391	0.00588	CcSEcCtD
Probenecid—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.00586	CcSEcCtD
Probenecid—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000389	0.00585	CcSEcCtD
Probenecid—Pain—Tretinoin—peripheral nervous system neoplasm	0.000388	0.00583	CcSEcCtD
Probenecid—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000388	0.00583	CcSEcCtD
Probenecid—Pain—Melphalan—peripheral nervous system neoplasm	0.000383	0.00576	CcSEcCtD
Probenecid—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00576	CcSEcCtD
Probenecid—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000375	0.00564	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00551	CcSEcCtD
Probenecid—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000365	0.00548	CcSEcCtD
Probenecid—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000364	0.00546	CcSEcCtD
Probenecid—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000364	0.00546	CcSEcCtD
Probenecid—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000362	0.00544	CcSEcCtD
Probenecid—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000361	0.00542	CcSEcCtD
Probenecid—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000361	0.00542	CcSEcCtD
Probenecid—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000359	0.00539	CcSEcCtD
Probenecid—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000359	0.00539	CcSEcCtD
Probenecid—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000357	0.00537	CcSEcCtD
Probenecid—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000356	0.00535	CcSEcCtD
Probenecid—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000354	0.00532	CcSEcCtD
Probenecid—Flushing—Etoposide—peripheral nervous system neoplasm	0.000351	0.00527	CcSEcCtD
Probenecid—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.00517	CcSEcCtD
Probenecid—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000337	0.00507	CcSEcCtD
Probenecid—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000334	0.00503	CcSEcCtD
Probenecid—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000334	0.00503	CcSEcCtD
Probenecid—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000334	0.00502	CcSEcCtD
Probenecid—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000332	0.00499	CcSEcCtD
Probenecid—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000331	0.00498	CcSEcCtD
Probenecid—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00033	0.00496	CcSEcCtD
Probenecid—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.00493	CcSEcCtD
Probenecid—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000324	0.00487	CcSEcCtD
Probenecid—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000323	0.00485	CcSEcCtD
Probenecid—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000321	0.00483	CcSEcCtD
Probenecid—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00483	CcSEcCtD
Probenecid—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00483	CcSEcCtD
Probenecid—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.00477	CcSEcCtD
Probenecid—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000317	0.00476	CcSEcCtD
Probenecid—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000316	0.00475	CcSEcCtD
Probenecid—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000304	0.00457	CcSEcCtD
Probenecid—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000303	0.00455	CcSEcCtD
Probenecid—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0003	0.00451	CcSEcCtD
Probenecid—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0003	0.00451	CcSEcCtD
Probenecid—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00449	CcSEcCtD
Probenecid—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000295	0.00443	CcSEcCtD
Probenecid—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.00442	CcSEcCtD
Probenecid—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00441	CcSEcCtD
Probenecid—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000293	0.00441	CcSEcCtD
Probenecid—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000291	0.00437	CcSEcCtD
Probenecid—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000289	0.00434	CcSEcCtD
Probenecid—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000289	0.00434	CcSEcCtD
Probenecid—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000288	0.00433	CcSEcCtD
Probenecid—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000288	0.00433	CcSEcCtD
Probenecid—Headache—Topotecan—peripheral nervous system neoplasm	0.000287	0.00431	CcSEcCtD
Probenecid—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000286	0.0043	CcSEcCtD
Probenecid—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000286	0.0043	CcSEcCtD
Probenecid—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000285	0.00428	CcSEcCtD
Probenecid—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000284	0.00427	CcSEcCtD
Probenecid—Headache—Tretinoin—peripheral nervous system neoplasm	0.000284	0.00427	CcSEcCtD
Probenecid—Pain—Vincristine—peripheral nervous system neoplasm	0.000283	0.00426	CcSEcCtD
Probenecid—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000282	0.00424	CcSEcCtD
Probenecid—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000279	0.0042	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00415	CcSEcCtD
Probenecid—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000273	0.00411	CcSEcCtD
Probenecid—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.00411	CcSEcCtD
Probenecid—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00409	CcSEcCtD
Probenecid—Nausea—Topotecan—peripheral nervous system neoplasm	0.000272	0.00409	CcSEcCtD
Probenecid—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00027	0.00405	CcSEcCtD
Probenecid—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00027	0.00405	CcSEcCtD
Probenecid—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000269	0.00404	CcSEcCtD
Probenecid—Nausea—Melphalan—peripheral nervous system neoplasm	0.000266	0.004	CcSEcCtD
Probenecid—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000262	0.00394	CcSEcCtD
Probenecid—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000256	0.00385	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00384	CcSEcCtD
Probenecid—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00383	CcSEcCtD
Probenecid—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.00381	CcSEcCtD
Probenecid—Pain—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00377	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00368	CcSEcCtD
Probenecid—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000244	0.00367	CcSEcCtD
Probenecid—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.00366	CcSEcCtD
Probenecid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000236	0.00355	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00352	CcSEcCtD
Probenecid—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000233	0.00351	CcSEcCtD
Probenecid—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000232	0.00348	CcSEcCtD
Probenecid—Pain—Etoposide—peripheral nervous system neoplasm	0.00023	0.00345	CcSEcCtD
Probenecid—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.00342	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.0034	CcSEcCtD
Probenecid—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00338	CcSEcCtD
Probenecid—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00022	0.00331	CcSEcCtD
Probenecid—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000219	0.00329	CcSEcCtD
Probenecid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.00329	CcSEcCtD
Probenecid—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00326	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00325	CcSEcCtD
Probenecid—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000216	0.00325	CcSEcCtD
Probenecid—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00324	CcSEcCtD
Probenecid—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000213	0.00321	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000212	0.00319	CcSEcCtD
Probenecid—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000211	0.00317	CcSEcCtD
Probenecid—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000209	0.00314	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00313	CcSEcCtD
Probenecid—Headache—Vincristine—peripheral nervous system neoplasm	0.000208	0.00312	CcSEcCtD
Probenecid—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.00307	CcSEcCtD
Probenecid—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00301	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000198	0.00297	CcSEcCtD
Probenecid—Nausea—Vincristine—peripheral nervous system neoplasm	0.000197	0.00296	CcSEcCtD
Probenecid—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00296	CcSEcCtD
Probenecid—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00019	0.00286	CcSEcCtD
Probenecid—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00281	CcSEcCtD
Probenecid—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000186	0.0028	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00279	CcSEcCtD
Probenecid—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000185	0.00278	CcSEcCtD
Probenecid—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00273	CcSEcCtD
Probenecid—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000178	0.00267	CcSEcCtD
Probenecid—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000174	0.00262	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.0026	CcSEcCtD
Probenecid—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000171	0.00257	CcSEcCtD
Probenecid—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00256	CcSEcCtD
Probenecid—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000169	0.00254	CcSEcCtD
Probenecid—Headache—Etoposide—peripheral nervous system neoplasm	0.000168	0.00253	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00248	CcSEcCtD
Probenecid—Nausea—Etoposide—peripheral nervous system neoplasm	0.000159	0.0024	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00237	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.0023	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00226	CcSEcCtD
Probenecid—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00216	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00209	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.002	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00197	CcSEcCtD
Probenecid—Pain—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00193	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00182	CcSEcCtD
Probenecid—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00012	0.0018	CcSEcCtD
Probenecid—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00179	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00179	CcSEcCtD
Probenecid—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00167	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00166	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00165	CcSEcCtD
Probenecid—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000106	0.0016	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00154	CcSEcCtD
Probenecid—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.95e-05	0.0015	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.00148	CcSEcCtD
Probenecid—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.00144	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.00143	CcSEcCtD
Probenecid—Headache—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.00142	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.00138	CcSEcCtD
Probenecid—Nausea—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.00134	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.00133	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.00132	CcSEcCtD
Probenecid—Headache—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.00131	CcSEcCtD
Probenecid—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.00124	CcSEcCtD
Probenecid—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	3.46e-05	0.001	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.45e-05	0.001	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	3.45e-05	0.001	CbGpPWpGaD
Probenecid—ABCC5—Disease—ENO2—peripheral nervous system neoplasm	3.38e-05	0.000982	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.38e-05	0.000981	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.37e-05	0.00098	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.31e-05	0.000961	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	3.3e-05	0.00096	CbGpPWpGaD
Probenecid—PANX1—Immune System—NRAS—peripheral nervous system neoplasm	3.29e-05	0.000955	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.25e-05	0.000945	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.25e-05	0.000942	CbGpPWpGaD
Probenecid—ABCC1—Disease—GNS—peripheral nervous system neoplasm	3.23e-05	0.000936	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	3.18e-05	0.000924	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.15e-05	0.000916	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	3.14e-05	0.000912	CbGpPWpGaD
Probenecid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.14e-05	0.000911	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.14e-05	0.00091	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.13e-05	0.000909	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.12e-05	0.000907	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.1e-05	0.000901	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.08e-05	0.000893	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.03e-05	0.00088	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.02e-05	0.000877	CbGpPWpGaD
Probenecid—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.01e-05	0.000874	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3e-05	0.000872	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	3e-05	0.000872	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	2.99e-05	0.000869	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.98e-05	0.000865	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.96e-05	0.000859	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.94e-05	0.000854	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—TH—peripheral nervous system neoplasm	2.94e-05	0.000853	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.93e-05	0.00085	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.89e-05	0.00084	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.89e-05	0.000839	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.88e-05	0.000836	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.85e-05	0.000827	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.84e-05	0.000824	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.84e-05	0.000823	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ENO2—peripheral nervous system neoplasm	2.83e-05	0.000823	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.82e-05	0.000818	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.78e-05	0.000808	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.77e-05	0.000804	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.74e-05	0.000796	CbGpPWpGaD
Probenecid—ABCC5—Disease—SLC2A1—peripheral nervous system neoplasm	2.73e-05	0.000792	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.72e-05	0.000789	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.71e-05	0.000787	CbGpPWpGaD
Probenecid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	2.71e-05	0.000786	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	2.7e-05	0.000784	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.7e-05	0.000783	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.000775	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.63e-05	0.000765	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.63e-05	0.000764	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.63e-05	0.000763	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	2.59e-05	0.000752	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.53e-05	0.000735	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.52e-05	0.000731	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	2.49e-05	0.000724	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.47e-05	0.000717	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.46e-05	0.000714	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.45e-05	0.000712	CbGpPWpGaD
Probenecid—PANX1—Immune System—HRAS—peripheral nervous system neoplasm	2.41e-05	0.000699	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.4e-05	0.000696	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—BCHE—peripheral nervous system neoplasm	2.39e-05	0.000695	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.37e-05	0.000687	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	2.35e-05	0.000683	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.35e-05	0.000683	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.32e-05	0.000674	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.32e-05	0.000673	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.29e-05	0.000666	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.29e-05	0.000664	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.28e-05	0.000663	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.27e-05	0.000658	CbGpPWpGaD
Probenecid—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	2.26e-05	0.000655	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	2.26e-05	0.000655	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—TH—peripheral nervous system neoplasm	2.25e-05	0.000653	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.25e-05	0.000653	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.23e-05	0.000646	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.22e-05	0.000646	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	2.19e-05	0.000637	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.18e-05	0.000634	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	2.17e-05	0.00063	CbGpPWpGaD
Probenecid—PANX1—Immune System—AKT1—peripheral nervous system neoplasm	2.13e-05	0.000617	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.12e-05	0.000616	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	2.1e-05	0.00061	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—TH—peripheral nervous system neoplasm	2.09e-05	0.000607	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	2.09e-05	0.000606	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.04e-05	0.000592	CbGpPWpGaD
Probenecid—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.03e-05	0.000589	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	2.02e-05	0.000587	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.97e-05	0.000573	CbGpPWpGaD
Probenecid—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	1.95e-05	0.000567	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000562	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.84e-05	0.000534	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	1.84e-05	0.000533	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.82e-05	0.000529	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.82e-05	0.000528	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.8e-05	0.000524	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.8e-05	0.000523	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.78e-05	0.000516	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	1.76e-05	0.000512	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—NRAS—peripheral nervous system neoplasm	1.76e-05	0.000511	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.75e-05	0.000509	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000498	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.71e-05	0.000496	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.7e-05	0.000492	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.69e-05	0.000489	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.68e-05	0.000489	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.68e-05	0.000487	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.66e-05	0.000482	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.66e-05	0.000482	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.64e-05	0.000478	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.64e-05	0.000475	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.63e-05	0.000472	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.62e-05	0.000471	CbGpPWpGaD
Probenecid—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.000457	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.54e-05	0.000446	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.53e-05	0.000444	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	1.52e-05	0.000443	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.51e-05	0.000439	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.49e-05	0.000433	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.48e-05	0.000428	CbGpPWpGaD
Probenecid—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.47e-05	0.000426	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.47e-05	0.000426	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.46e-05	0.000425	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.44e-05	0.000419	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.43e-05	0.000414	CbGpPWpGaD
Probenecid—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000413	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.41e-05	0.000411	CbGpPWpGaD
Probenecid—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.41e-05	0.000408	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.38e-05	0.000401	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.38e-05	0.000401	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.36e-05	0.000396	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.36e-05	0.000395	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000393	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.35e-05	0.000393	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.35e-05	0.000393	CbGpPWpGaD
Probenecid—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.35e-05	0.000393	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—peripheral nervous system neoplasm	1.35e-05	0.000391	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.000389	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.33e-05	0.000386	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.33e-05	0.000386	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.32e-05	0.000383	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.32e-05	0.000382	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.31e-05	0.000381	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.3e-05	0.000377	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—HRAS—peripheral nervous system neoplasm	1.29e-05	0.000374	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.29e-05	0.000373	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.000366	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.23e-05	0.000358	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.23e-05	0.000357	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.22e-05	0.000353	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.21e-05	0.000351	CbGpPWpGaD
Probenecid—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	1.2e-05	0.00035	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.00035	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.2e-05	0.000349	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.19e-05	0.000344	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.18e-05	0.000342	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.16e-05	0.000336	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.15e-05	0.000334	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.000334	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—AKT1—peripheral nervous system neoplasm	1.14e-05	0.00033	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000329	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.12e-05	0.000326	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.12e-05	0.000326	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.11e-05	0.000322	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.1e-05	0.000318	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000313	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.07e-05	0.000311	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.06e-05	0.000308	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.06e-05	0.000307	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	1.06e-05	0.000306	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.05e-05	0.000304	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-05	0.000302	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1e-05	0.000291	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	9.88e-06	0.000287	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	9.6e-06	0.000279	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.24e-06	0.000268	CbGpPWpGaD
Probenecid—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	9.17e-06	0.000266	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.07e-06	0.000263	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8.94e-06	0.000259	CbGpPWpGaD
Probenecid—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	8.89e-06	0.000258	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	8.81e-06	0.000256	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.68e-06	0.000252	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	8.61e-06	0.00025	CbGpPWpGaD
Probenecid—ABCC5—Disease—MYC—peripheral nervous system neoplasm	8.54e-06	0.000248	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	8.48e-06	0.000246	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.45e-06	0.000245	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.98e-06	0.000232	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.92e-06	0.00023	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.79e-06	0.000226	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.59e-06	0.00022	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	7.55e-06	0.000219	CbGpPWpGaD
Probenecid—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	7.51e-06	0.000218	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	7.44e-06	0.000216	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.33e-06	0.000213	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.31e-06	0.000212	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.27e-06	0.000211	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.2e-06	0.000209	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.16e-06	0.000208	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	7.1e-06	0.000206	CbGpPWpGaD
Probenecid—ALB—Metabolism—TH—peripheral nervous system neoplasm	7.06e-06	0.000205	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	6.96e-06	0.000202	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.74e-06	0.000196	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	6.71e-06	0.000195	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.58e-06	0.000191	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.47e-06	0.000188	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.43e-06	0.000187	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.34e-06	0.000184	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.28e-06	0.000182	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.18e-06	0.00018	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.15e-06	0.000178	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	5.94e-06	0.000172	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	5.92e-06	0.000172	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.86e-06	0.00017	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.8e-06	0.000168	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.78e-06	0.000168	CbGpPWpGaD
Probenecid—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	5.76e-06	0.000167	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.69e-06	0.000165	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	5.65e-06	0.000164	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	5.3e-06	0.000154	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.17e-06	0.00015	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.08e-06	0.000147	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.05e-06	0.000147	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	4.96e-06	0.000144	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—peripheral nervous system neoplasm	4.93e-06	0.000143	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.8e-06	0.000139	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.72e-06	0.000137	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.63e-06	0.000134	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.61e-06	0.000134	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	4.54e-06	0.000132	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.34e-06	0.000126	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.05e-06	0.000118	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	3.87e-06	0.000112	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.87e-06	0.000112	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3.84e-06	0.000111	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.81e-06	0.000111	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	3.66e-06	0.000106	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.42e-06	9.93e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.18e-06	9.24e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.11e-06	9.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.05e-06	8.86e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.86e-06	8.32e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.49e-06	7.24e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.33e-06	6.75e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-06	4.54e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-06	4.52e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.4e-06	4.05e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.36e-06	3.96e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-06	3.7e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.4e-07	2.44e-05	CbGpPWpGaD
